Structural modelling and in silico pharmacology of β-carboline alkaloids as potent 5-HT1A receptor antagonists and reuptake inhibitors

被引:29
|
作者
Ayipo, Yusuf Oloruntoyin [1 ,2 ]
Alananzeh, Waleed A. [1 ]
Ahmad, Iqrar [3 ]
Patel, Harun [3 ]
Mordi, Mohd Nizam [1 ]
机构
[1] Univ Sains Malaysia, Ctr Drug Res, George Town 11800, Malaysia
[2] Kwara State Univ, Dept Chem & Ind Chem, Ilorin, Nigeria
[3] RC Patel Inst Pharmaceut Educ & Res, Dept Pharmaceut Chem, Shirpur, Maharashtra, India
来源
关键词
Major depressive disorder; structural modelling; molecular pharmacology; molecular dynamics; drug design; FORCE-FIELD; PROTEIN; DOCKING; RECOGNITION; COVERAGE; ERRORS;
D O I
10.1080/07391102.2022.2104376
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Serotonin (5-HT) antagonists and reuptake inhibitors (SARIs) are atypical antidepressants for managing major depressive disorder. They are oftentimes applied as adjuvants for ameliorating aftereffects of SSRI antidepressants including insomnia and sexual dysfunction. The few available candidates of this class including lorpiprazole and trazodone also display some daunting side effects, making a continuous search for improved alternatives essential. Natural beta-carboline alkaloids (N beta Cs) are interestingly renowned with broad pharmacological spectrum against several neuropsychiatric disorders including depression. However, their potentials as SARIs remain underexplored. In this study, 982 N beta Cs retrieved from the Ambinter-Greenpharma (Amb) database were virtually screened for potent SARI alternatives using computational and biocheminformatics approaches: homology modelling of 5-HT1A receptor, Glide HTVS, SP and XP molecular docking, molecular dynamics (MD) simulation, ADMET and mutagenicity predictions. The homology receptor was validated as a good representative of human 5HT1A receptor using the RCSB structure validation and quality protocols. From the virtual screening against the 5-HT1A receptor, Amb ligands, Amb18709727 and Amb37857532 showed higher binding affinities by XP scores of -8.725 and -7.976 kcal/mol, and MMGBSA of -87.972 and -107.585 kcal/mol respectively compared to lorpiprazole, a reference SARI with XP score and MMGBSA of -6.512 and -62.788 kcal/mol respectively. They maintained ideal contacts with pharmacologically essential amino acid residues implicated in SARI mechanisms and expressed higher stability and compactness than lorpiprazole throughout the trajectories of 100 ns MD simulation. They also displayed interesting ADME, druggability, low toxicity and mutagenicity profiles, ideal for CNS drug prospects, thus, recommended as putative SARI candidates for further study.
引用
收藏
页码:6219 / 6235
页数:17
相关论文
共 50 条
  • [41] Design and synthesis of potent and selective 5-HT1A receptor ligands.
    Zhang, G
    Palmer, Y
    Kelly, MG
    Smith, DL
    Schechter, LE
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 220 : U557 - U557
  • [42] High potent and selective arylpiperazine derivatives as ligands for the 5-HT1A receptor
    Modica, M
    Santagati, M
    Santagati, A
    Russo, F
    Cagnotto, A
    Goegan, M
    Mennini, T
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (10) : 1089 - 1092
  • [43] The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor
    Jordan, S
    Koprivica, V
    Chen, RY
    Tottori, K
    Kikuchi, T
    Altar, CA
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 441 (03) : 137 - 140
  • [44] NOVEL INDOLODIOXANES WITH ANTIHYPERTENSIVE EFFECTS - POTENT LIGANDS FOR THE 5-HT1A RECEPTOR
    ENNIS, MD
    BAZE, ME
    SMITH, MW
    LAWSON, CF
    MCCALL, RB
    LAHTI, RA
    PIERCEY, MF
    JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (16) : 3058 - 3066
  • [45] Synthesis and SAR of highly potent dual 5-HT1A and 5-HT1B antagonists as potential antidepressant drugs
    Kling, A
    Lange, UEW
    Mack, H
    Bakker, MHM
    Drescher, KU
    Hornberger, W
    Hutchins, CW
    Möller, A
    Müller, R
    Schmidt, M
    Unger, L
    Wicke, K
    Schellhaas, K
    Steiner, G
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (24) : 5567 - 5573
  • [46] Restraint accentuates the effects of 5-HT2 receptor antagonists and a 5-HT1A receptor agonist on lordosis behavior
    Uphouse, L
    White, S
    Harrison, L
    Hiegel, C
    Majumdar, D
    Guptarak, J
    Truitt, WA
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2003, 76 (01) : 63 - 73
  • [47] Synthesis and structure-activity relationship in a class of indolebutylpiperazines as dual 5-HT1A receptor agonists and serotonin reuptake inhibitors
    Heinrich, T
    Böttcher, H
    Gericke, R
    Bartoszyk, GD
    Anzali, S
    Seyfried, CA
    Greiner, HE
    van Amsterdam, C
    JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (19) : 4684 - 4692
  • [48] Early response to selective serotonin reuptake inhibitors in panic disorder is associated with a functional 5-HT1A receptor gene polymorphism
    Yevtushenko, Olga O.
    Oros, Mykhaylo M.
    Reynolds, Gavin P.
    JOURNAL OF AFFECTIVE DISORDERS, 2010, 123 (1-3) : 308 - 311
  • [49] Structural Characterization of New Potential 5-HT1A Receptor Ligands
    Wolska, Irena
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2006, 62 : S301 - S301
  • [50] A SERIES OF POTENT AND SELECTIVE 5-HT1A RECEPTOR ANTAGONISTS RELATED TO WAY-100135 - SYNTHESES, SAR, AND MODELING STUDIES
    BILL, SJ
    CLIFFE, IA
    DOVER, GM
    FLETCHER, A
    FORSTER, EA
    IFILL, AD
    MANSELL, HL
    PITT, W
    REILLY, Y
    WHITE, AC
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1995, 209 : 59 - MEDI